Back to Search Start Over

Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

Source :
Thomson Reuters ONE. January 22, 2025
Publication Year :
2025

Abstract

(GLOBE NEWSWIRE via COMTEX) -- Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma - Approval is [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Thomson Reuters ONE
Publication Type :
News
Accession number :
edsgcl.824385090